| Application no. and date | 02014594.2 (espacenet) (Federated) (European Patent Register), 20020702 | | Patent/reg. no. and date | DK/EP 1291021, 20051214 | | Publication date | 20030312 | | Priority no. and date | IT MI20011401, 20010702 | | EP pub. no. and date |
EP 1291021 20030312 | | Effective date | | | Applicant/owner | ALTERGON S.A., Via Dogana
Vecchia 2
CH-6903 Lugano, CH | | Applicant ref. no. | P40345DK01 | | Inventor | Di Martino, Alessandro, via San Calocero, 4
20123 Milano, IT,
Marchiorri, Maurizio, via Don Orsenigo, 11
22039 Valbrona, IT,
Mateo Echanagorria, Angel, Residenza Cantone, 121
20090 Segrate, IT,
Garavani, Alberto, Gradinata Pometta 6
6900 Massagno, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 38/24 (2006.01) , A61K 9/48 (2006.01) | | Title | Farmaceutiske formuleringer som omfatter thyroideahormoner | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
